north carolina hiv/std quarterly surveillance report: vol....
TRANSCRIPT
North Carolina HIV/STD Quarterly Surveillance Report: Vol. 2007, No. 3 Epidemiology & Special Studies Unit
HIV/STD Prevention and Care Branch 1902 Mail Service Center Epidemiology Section, Division of Public Health Raleigh, North Carolina 27699-1902 North Carolina Department of Health & Human Services (919) 733-7301
ANNOUNCEMENTS: Readers are cautioned that these data represent reports for short time periods and that changes noted from quarter to quarter may not be meaningful. Reporting delays and changes can substantially affect counts. Reports are counted by county of residence for the case. For persons diagnosed in long-term institutions such as prisons and some treatment facilities, the institution is considered the cases’ address. Disease counts for counties with such facilities may be higher than expected otherwise. Readers will also note that HIV disease reports for 2006 are up significantly compared to the same period in earlier years. In recent years, laboratory reporting in North Carolina has been enhanced with the addition of required reporting of HIV viral load results and certain CD4 results. Follow up surveillance activities for these laboratory reports is given a high priority. Thus, this increase in 2006 reports may be the result of enhanced surveillance activities as well as a general increase in the number of new HIV diagnoses. If you have questions or comments, please contact us at the address or phone number above.
About the authors North Carolina law requires that diagnoses of certain communicable diseases, including sexually transmitted diseases (STDs), be reported to local health departments that in turn report the information to the state. The Epidemiology and Special Studies Unit (ESSU) is the designated recipient for STD morbidity reports at the state level and is responsible for aggregating reports and providing statewide information about these diseases to others, including the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The ESSU is part of the HIV/STD Prevention and Care Branch within the North Carolina Division of Public Health.
About the contents of this report The North Carolina HIV/STD Surveillance Report: Vol. 2007, No.3 presents statistics and trends of sexually transmitted diseases (including HIV and AIDS) in North Carolina from January 1 through September 30, 2007. All reports are presented by the date received by the ESSU. This report is intended as a reference document for local health departments, program managers, health planners, researchers and others who are concerned with the public health implications of these diseases. The information in this quarterly report is meant to be brief and provide limited data on these diseases throughout the year. More detailed and complete information will continue to be available in annual publications. This report and our annual publications are available on our website (www.epi.state.nc.us/epi/hiv/surveillance.html). The CDC maintains data about these diseases for the United States; national information is available from its website (www.cdc.gov).
State of North Carolina ● Michael F. Easley, Governor
Department of Health & Human Services ● Division of Public Health NC DHHS is an equal opportunity employer and provider. www.ncdhhs.gov
10/07
10/07
NC HIV/STD Quarterly Surveillance Report Vol. 2007 No. 3
NCDHHS HIV/STD Prev. & Care 2
AIDS and HIV disease surveillance data HIV disease case reports represent persons who have a confirmed diagnosis with human immunodeficiency virus (HIV). This category represents all new diagnoses with HIV regardless of the stage of the disease. Most persons are reported with only an HIV infection, but some persons are reported with a concurrent diagnosis of AIDS (acquired immunodeficiency syndrome). In North Carolina, about one-third of the new HIV disease reports represent persons who are diagnosed with HIV infection and AIDS at the same time. AIDS case reports, by contrast, represent only persons with HIV infection who have progressed to this later, more life threatening, stage of disease. Most AIDS case reports represent persons who were diagnosed with HIV infection in earlier years. For these reasons, HIV disease reports and AIDS case reports should be considered separately. The two categories should never be combined to estimate an infected population, as the broad group of HIV disease includes AIDS cases but the time references are different. Chlamydia surveillance data Chlamydia case reports represent persons who have a laboratory-confirmed chlamydial infection. It is important to note that chlamydial infection is often asymptomatic in both males and females, and most cases are detected through screening. Changes in the number of reported cases may be due to changes in screening practices. The disease can cause serious complications in females, and a number of screening programs are in place to detect infection in young women. There are no comparable screening programs for young men. For this reason, chlamydia case reports are always highly biased with respect to gender. Gonorrhea surveillance data Gonorrhea case reports represent persons who have a laboratory-confirmed gonorrhea infection. Gonorrhea is often symptomatic in males and slightly less so in females. Many cases are detected when patients seek medical care. Others are detected through screening but to a far lesser degree than chlamydia cases. Gonorrhea can cause serious complications for females and a number of screening programs exist targeting this population. There is less screening of males but since they are more likely to have symptoms that would bring them to the STD clinic, gender bias in gonorrhea reporting is not likely to be large. Public clinics and health departments may do a better job of conducting such screening programs and reporting cases, causing the reported cases to be biased toward those attending public clinics. Syphilis surveillance data Syphilis cases are reported by stage of infection, which is determined through a combination of laboratory testing and patient interviews. Primary and secondary syphilis have very specific symptoms associated with them, so misclassification of these stages is highly unlikely. Early latent syphilis is asymptomatic but can be staged with confirmation that the infection is less than a year old. Together these three stages that occur within the first year of infection are called ‘early syphilis’. This report includes only early syphilis cases, though other later stages are reported to ESSU. Because North Carolina performs patient interviews, partner notification, and contact tracing on all early syphilis cases, the quality of the early latent case data is also quite good. Screening programs are more likely to detect asymptomatic cases, which may introduce some bias in the early latent case reports toward screened populations (pregnant women, jail inmates, others). But, thorough contact tracing further aids in case detection and reduces these biases. For more information The data descriptions provided on this page are succinct. For a more detailed discussion of the content, strengths, and weaknesses of STD and HIV surveillance data, please see pages 131-148 in the Epidemiologic Profile for HIV/STD Prevention & Care Planning, August 2006. This report can be found on our website www.epi.state.nc.us/epi/hiv/epiprofile0806.html .
NC HIV/STD Quarterly Surveillance Report Vol. 2007 No. 3
NCDHHS HIV/STD Prev. & Care 3
NORTH CAROLINA HIV DISEASE † CASES
COUNTY 2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
ALAMANCE 26 14 14ALEXANDER 3 2 0ALLEGHANY 0 0 2ANSON 1 5 0ASHE 0 2 3AVERY 0 0 1BEAUFORT 3 5 3BERTIE 4 2 5BLADEN 2 4 2BRUNSWICK 6 8 6BUNCOMBE 8 21 31BURKE 6 1 1CABARRUS 16 9 10CALDWELL 5 3 0CAMDEN 1 1 1CARTERET 0 3 3CASWELL 0 2 4CATAWBA 6 14 3CHATHAM 2 0 4CHEROKEE 2 2 3CHOWAN 3 0 1CLAY 0 0 0CLEVELAND 24 10 9COLUMBUS 10 12 10CRAVEN 11 23 17CUMBERLAND 50 104 51CURRITUCK 1 2 2DARE 1 2 0DAVIDSON 14 9 5DAVIE 2 2 0DUPLIN 7 10 9DURHAM 74 78 66EDGECOMBE 14 23 22FORSYTH 72 71 57FRANKLIN 6 11 2GASTON 19 30 12GATES 0 1 0GRAHAM 0 0 0GRANVILLE 13 5 6GREENE 1 6 1GUILFORD 88 124 94HALIFAX 8 8 6HARNETT 5 19 3HAYWOOD 5 2 5HENDERSON 2 3 3HERTFORD 9 80 14HOKE 1 12 5HYDE 0 0 0IREDELL 11 10 4JACKSON 0 5 0JOHNSTON 14 24 9JONES 1 0 0LEE 4 10 5
NORTH CAROLINA HIV DISEASE † CASES
COUNTY 2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
LENOIR 14 19 18LINCOLN 2 2 1MACON 2 1 1MADISON 0 2 0MARTIN 5 7 7MCDOWELL 2 4 1MECKLENBURG 239 321 260MITCHELL 0 0 1MONTGOMERY 3 0 4MOORE 12 11 8NASH 15 21 16NEW HANOVER 42 49 27NORTHAMPTON 1 3 3ONSLOW 12 10 10ORANGE 11 15 8PAMLICO 2 2 1PASQUOTANK 2 11 3PENDER 4 3 1PERQUIMANS 2 1 0PERSON 0 1 8PITT 23 19 22POLK 0 0 0RANDOLPH 7 7 7RICHMOND 8 11 13ROBESON 28 23 30ROCKINGHAM 8 4 2ROWAN 19 11 16RUTHERFORD 2 7 0SAMPSON 8 17 4SCOTLAND 6 7 5STANLY 1 4 5STOKES 5 1 2SURRY 9 2 2SWAIN 0 0 0TRANSYLVANIA 1 1 2TYRRELL 0 0 0UNION 6 8 12VANCE 5 6 10WAKE 138 201 148WARREN 2 4 1WASHINGTON 7 2 6WATAUGA 4 2 0WAYNE 14 26 20WILKES 2 2 3WILSON 20 20 13YADKIN 2 2 0YANCEY 0 0 1UNKNOWN 0 2 9TOTAL 1,256 1,666 1,225
†HIV Disease includes all newly reported HIV infected individuals by the date of first report (HIV or AIDS)
NC HIV/STD Quarterly Surveillance Report Vol. 2007 No. 3
NCDHHS HIV/STD Prev. & Care 4
NORTH CAROLINA SEXUALLY TRANSMITTED DISEASE CASES CHLAMYDIA GONORRHEA P. & S. SYPHILIS E. L. SYPHILIS
YEAR TO DATE 2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
ALAMANCE 302 280 334 124 168 159 3 3 5 0 3 1ALEXANDER 37 38 27 7 17 10 1 0 0 1 0 0ALLEGHANY 0 0 2 0 0 0 0 0 0 0 0 0ANSON 137 67 96 65 58 56 0 0 0 0 1 0ASHE 9 15 9 1 0 1 0 0 0 0 0 0AVERY 3 4 5 0 0 0 0 0 0 0 0 0BEAUFORT 129 130 137 34 59 61 0 0 0 0 1 0BERTIE 115 107 85 73 59 37 0 0 0 0 1 0BLADEN 107 129 104 35 48 24 1 0 0 2 3 0BRUNSWICK 125 156 164 99 107 57 1 1 1 1 1 3BUNCOMBE 448 407 423 178 251 144 2 3 3 3 1 2BURKE 88 110 90 38 77 39 0 0 2 3 0 0CABARRUS 319 281 425 114 136 160 3 3 1 0 1 1CALDWELL 118 96 111 28 38 65 0 0 0 0 0 0CAMDEN 10 11 15 6 4 4 0 0 0 0 0 0CARTERET 85 96 100 64 58 27 0 0 0 0 0 2CASWELL 57 59 23 16 27 17 0 0 0 0 0 0CATAWBA 258 325 289 103 170 148 1 0 2 0 0 0CHATHAM 46 60 61 33 28 30 1 1 1 2 0 0CHEROKEE 10 11 33 1 1 1 0 0 0 1 0 0CHOWAN 38 48 38 22 48 21 0 0 0 0 0 0CLAY 4 4 6 0 1 2 0 0 0 0 0 0CLEVELAND 319 253 242 236 170 132 3 2 2 2 0 1COLUMBUS 169 180 116 101 100 51 1 0 0 1 1 2CRAVEN 473 453 310 141 134 81 0 1 6 0 1 5CUMBERLAND 1,983 1,530 1,743 735 661 900 8 11 9 6 8 3CURRITUCK 23 30 26 5 28 8 0 0 0 0 0 0DARE 50 45 41 15 12 10 0 0 0 0 0 0DAVIDSON 224 219 239 114 83 93 1 0 0 0 1 1DAVIE 46 63 38 25 24 24 1 1 0 0 0 1DUPLIN 114 149 150 38 90 54 0 0 0 0 1 2DURHAM 1,093 950 804 554 538 438 8 9 23 2 13 13EDGECOMBE 389 388 379 253 279 229 0 3 2 0 2 6FORSYTH 1,339 1,406 1,626 519 612 554 5 6 5 6 17 9FRANKLIN 68 117 110 40 55 57 1 0 1 0 0 3GASTON 613 489 527 449 368 240 1 8 4 4 4 2GATES 41 32 24 20 18 9 0 0 0 0 0 0GRAHAM 1 4 4 0 0 0 0 0 0 0 0 0GRANVILLE 134 178 123 47 76 40 0 0 1 0 0 0GREENE 74 52 77 49 31 39 0 0 1 0 0 1GUILFORD 1,369 1,477 1,680 643 813 1,033 27 15 18 21 32 12HALIFAX 316 333 362 162 158 162 1 2 1 1 0 2HARNETT 180 192 187 92 125 98 0 0 0 0 1 1HAYWOOD 54 50 49 8 3 9 0 0 0 0 0 0HENDERSON 122 125 106 34 65 35 0 0 0 0 0 0HERTFORD 65 127 73 37 66 25 0 1 0 0 0 0HOKE 132 77 83 49 34 22 0 0 0 0 0 0HYDE 9 7 12 3 2 2 0 1 0 0 0 0IREDELL 231 251 233 151 214 162 0 2 0 0 1 1JACKSON 39 35 48 5 5 7 0 0 0 0 0 0JOHNSTON 135 267 190 68 152 99 1 6 5 2 1 5
NC HIV/STD Quarterly Surveillance Report Vol. 2007 No. 3
NCDHHS HIV/STD Prev. & Care 5
NORTH CAROLINA SEXUALLY TRANSMITTED DISEASE CASES CHLAMYDIA GONORRHEA P. & S. SYPHILIS E. L. SYPHILIS
YEAR TO DATE 2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
JONES 24 21 27 15 8 9 1 0 0 0 0 0LEE 115 143 126 66 83 41 2 1 0 0 2 0LENOIR 294 246 242 183 150 112 4 0 3 1 1 2LINCOLN 55 73 84 23 32 17 0 0 1 0 0 0MACON 32 21 26 2 3 1 0 0 0 1 0 0MADISON 16 27 14 3 1 3 0 0 0 0 0 0MARTIN 82 118 101 48 69 27 0 2 1 0 0 0MCDOWELL 30 40 38 6 5 20 1 0 0 1 0 1MECKLENBURG 2,708 2,098 1,310 1,513 1,562 717 67 74 70 42 67 28MITCHELL 5 10 8 1 2 0 0 0 0 0 0 0MONTGOMERY 28 32 45 21 22 14 1 0 0 0 1 0MOORE 186 172 161 51 84 50 0 0 2 1 1 0NASH 295 347 334 147 222 201 2 5 6 1 8 6NEW HANOVER 610 585 524 266 274 207 2 7 13 4 4 16NORTHAMPTON 119 118 118 50 60 43 0 2 0 0 1 0ONSLOW 716 965 725 301 307 127 0 1 1 0 1 1ORANGE 193 232 180 87 81 60 0 1 4 0 1 2PAMLICO 14 30 20 4 8 2 0 0 0 0 0 0PASQUOTANK 148 127 112 96 83 63 0 0 0 0 0 0PENDER 114 107 82 47 45 31 0 0 0 0 0 1PERQUIMANS 47 20 38 22 17 14 0 1 0 0 1 0PERSON 86 68 64 40 27 31 0 3 0 0 0 0PITT 712 671 661 406 390 299 1 1 3 0 3 2POLK 14 16 22 6 4 6 0 0 0 0 0 0RANDOLPH 162 144 171 58 62 40 6 1 0 4 2 1RICHMOND 151 146 149 48 94 83 0 0 0 0 0 0ROBESON 731 624 592 399 317 291 6 0 5 9 4 8ROCKINGHAM 188 182 165 90 95 76 1 2 2 1 0 2ROWAN 389 351 280 148 164 134 2 0 2 0 0 1RUTHERFORD 127 123 121 111 108 72 0 0 0 0 0 1SAMPSON 138 128 128 82 89 101 0 0 1 1 1 2SCOTLAND 148 148 176 90 109 92 1 0 1 0 0 0STANLY 98 94 78 67 46 31 0 0 2 1 1 1STOKES 23 7 64 7 3 16 2 0 0 0 0 0SURRY 57 56 49 16 18 6 0 2 0 1 1 0SWAIN 32 37 27 8 3 0 0 0 0 0 0 0TRANSYLVANIA 56 27 18 20 12 14 0 0 1 0 0 0TYRRELL 12 6 11 4 4 2 0 0 0 0 0 0UNION 247 184 157 141 114 109 3 3 0 1 0 0VANCE 178 314 208 91 132 112 0 0 0 2 3 0WAKE 1,896 3,162 2,072 724 1,208 704 22 26 22 18 23 10WARREN 68 87 94 27 37 39 1 0 0 0 0 0WASHINGTON 37 54 56 26 35 15 1 0 0 0 0 0WATAUGA 33 19 12 3 5 1 0 1 0 0 0 0WAYNE 411 361 266 170 168 80 2 6 7 2 4 5WILKES 30 54 51 11 17 4 1 0 0 0 0 0WILSON 328 346 342 278 331 269 3 5 1 1 0 2YADKIN 32 40 40 17 13 16 2 0 1 0 0 0YANCEY 5 13 8 2 4 2 0 0 0 0 0 0UNKNOWN 0 0 0 0 0 0 0 0 0 0 0 0TOTAL 24,470 24,907 22,576 11,676 12,998 10,080 205 223 242 150 225 171
NC HIV/STD Quarterly Surveillance Report Vol. 2007 No. 3
NCDHHS HIV/STD Prev. & Care 6
NORTH CAROLINA AIDS* CASES
COUNTY 2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
ALAMANCE 11 2 7ALEXANDER 1 3 0ALLEGHANY 0 0 0ANSON 5 1 3ASHE 0 1 0AVERY 0 0 1BEAUFORT 4 2 1BERTIE 5 3 3BLADEN 1 5 2BRUNSWICK 2 7 3BUNCOMBE 7 8 7BURKE 3 3 0CABARRUS 1 6 6CALDWELL 2 0 0CAMDEN 1 1 0CARTERET 0 1 1CASWELL 0 1 2CATAWBA 4 7 5CHATHAM 1 0 1CHEROKEE 0 2 1CHOWAN 2 2 0CLAY 0 0 0CLEVELAND 6 8 7COLUMBUS 3 10 8CRAVEN 11 23 17CUMBERLAND 21 37 33CURRITUCK 0 1 0DARE 0 0 0DAVIDSON 4 0 3DAVIE 0 2 0DUPLIN 3 5 2DURHAM 32 31 25EDGECOMBE 10 5 10FORSYTH 27 23 22FRANKLIN 4 4 3GASTON 18 8 7GATES 0 1 0GRAHAM 0 0 0GRANVILLE 8 4 3GREENE 1 2 1GUILFORD 30 35 36HALIFAX 3 10 4HARNETT 7 8 4HAYWOOD 4 2 1HENDERSON 2 1 4HERTFORD 0 26 8HOKE 1 5 2HYDE 0 0 0IREDELL 6 4 3JACKSON 0 1 0JOHNSTON 9 18 6JONES 0 1 0LEE 1 5 5
NORTH CAROLINA AIDS* CASES
COUNTY 2005 Jan-Sep
2006 Jan-Sep
2007 Jan-Sep
LENOIR 10 8 9LINCOLN 2 3 0MACON 0 0 0MADISON 0 0 0MARTIN 4 4 2MCDOWELL 3 1 2MECKLENBURG 105 143 132MITCHELL 0 0 1MONTGOMERY 3 0 0MOORE 2 5 5NASH 10 8 14NEW HANOVER 16 27 15NORTHAMPTON 2 1 1ONSLOW 4 3 3ORANGE 4 5 3PAMLICO 1 0 0PASQUOTANK 1 4 2PENDER 3 1 1PERQUIMANS 3 0 1PERSON 0 0 6PITT 16 14 17POLK 0 0 1RANDOLPH 3 6 4RICHMOND 4 4 6ROBESON 18 11 20ROCKINGHAM 1 1 3ROWAN 5 9 7RUTHERFORD 4 0 1SAMPSON 4 9 6SCOTLAND 4 3 3STANLY 2 1 3STOKES 0 0 2SURRY 2 0 0SWAIN 0 1 0TRANSYLVANIA 0 1 1TYRRELL 0 0 1UNION 3 8 7VANCE 4 5 7WAKE 78 122 101WARREN 1 1 0WASHINGTON 1 3 3WATAUGA 2 1 0WAYNE 10 27 14WILKES 0 1 2WILSON 13 15 11YADKIN 0 2 0YANCEY 0 1 1UNKNOWN 0 1 23TOTAL 609 795 698
*includes all AIDS cases by date of report for an AIDS diagnosis
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
H
IV/S
TD P
rev.
& C
are
7
Nor
th C
arol
ina
HIV
† Dis
ease
Cas
es b
y G
ende
r and
Age
, 200
7
1st Q
tr
2nd
Qtr
3r
d Q
tr
4th
Qtr
Ye
ar to
Dat
e A
GE
Cas
esPc
t C
ases
Pct
Cas
esPc
t C
ases
Pct
Cas
esPc
t
0-12
Yea
rs
2 0.
4%
1 0.
2%
1 0.
3%
n/a
n/a
4 0.
3%
13-1
9 Ye
ars
14
3.0%
15
3.
2%
11
3.8%
n/
a n/
a40
3.
3%
20-2
9 Ye
ars
87
18.4
%
83
17.9
%
52
18.1
%
n/a
n/a
222
18.1
%
30-3
9 Ye
ars
88
18.6
%
80
17.2
%
52
18.1
%
n/a
n/a
220
18.0
%
40-4
9 Ye
ars
86
18.2
%
95
20.5
%
57
19.8
%
n/a
n/a
238
19.4
%
50 a
nd o
ver
59
12.5
%
54
11.6
%
35
12.2
%
n/a
n/a
148
12.1
%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Mal
e
Tota
l 33
6 71
.0%
32
8 70
.7%
20
8 72
.2%
n/
a n/
a87
2 71
.2%
0-12
Yea
rs
n/a
0.0%
2
0.4%
n/
a 0.
0%
n/a
n/a
2 0.
2%
13-1
9 Ye
ars
8 1.
7%
6 1.
3%
2 0.
7%
n/a
n/a
16
1.3%
20-2
9 Ye
ars
31
6.6%
28
6.
0%
15
5.2%
n/
a n/
a74
6.
0%
30-3
9 Ye
ars
32
6.8%
40
8.
6%
32
11.1
%
n/a
n/a
104
8.5%
40-4
9 Ye
ars
38
8.0%
33
7.
1%
18
6.3%
n/
a n/
a89
7.
3%
50 a
nd o
ver
28
5.9%
27
5.
8%
13
4.5%
n/
a n/
a68
5.
6%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Fem
ale
Tota
l 13
7 29
.0%
13
6 29
.3%
80
27
.8%
n/
a n/
a35
3 28
.8%
0-12
Yea
rs
2 0.
4%
3 0.
6%
1 0.
3%
n/a
n/a
6 0.
5%
13-1
9 Ye
ars
22
4.7%
21
4.
5%
13
4.5%
n/
a n/
a56
4.
6%
20-2
9 Ye
ars
118
24.9
%
111
23.9
%
67
23.3
%
n/a
n/a
296
24.2
%
30-3
9 Ye
ars
120
25.4
%
120
25.9
%
84
29.2
%
n/a
n/a
324
26.4
%
40-4
9 Ye
ars
124
26.2
%
128
27.6
%
75
26.0
%
n/a
n/a
327
26.7
%
50 a
nd o
ver
87
18.4
%
81
17.5
%
48
16.7
%
n/a
n/a
216
17.6
%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Tota
l
Tota
l 47
3 10
0.0%
464
100.
0%28
8 10
0.0%
n/
a n/
a1,
225
100.
0%† H
IV D
isea
se in
clud
es a
ll ne
wly
repo
rted
HIV
infe
cted
indi
vidu
als
by th
e da
te o
f firs
t rep
ort (
HIV
or A
IDS
)
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
H
IV/S
TD P
rev.
& C
are
8
Nor
th C
arol
ina
HIV
† Dis
ease
Cas
es b
y G
ende
r and
Rac
e/Et
hnic
ity, 2
007
1s
t Qtr
2n
d Q
tr
3rd
Qtr
4t
h Q
tr
Year
to D
ate
RA
CE/
ETH
NIC
ITY
Cas
esPc
t C
ases
Pct
Cas
esPc
t C
ases
Pct
Cas
esPc
t
Whi
te**
10
1 21
.4%
10
6 22
.8%
64
22
.2%
n/
a n/
a27
1 22
.1%
Bla
ck**
19
0 40
.2%
18
9 40
.7%
12
4 43
.1%
n/
a n/
a50
3 41
.1%
Am
.In/A
N**
1 0.
2%
2 0.
4%
2 0.
7%
n/a
n/a
5 0.
4%
Asi
an,P
I**
2 0.
4%
1 0.
2%
1 0.
3%
n/a
n/a
4 0.
3%
His
pani
c 42
8.
9%
30
6.5%
16
5.
6%
n/a
n/a
88
7.2%
Unk
now
n n/
a 0.
0%
n/a
0.0%
1
0.3%
n/
a n/
a1
0.1%
Mal
e
Tota
l 33
6 71
.0%
32
8 70
.7%
20
8 72
.2%
n/
a n/
a87
2 71
.2%
Whi
te**
23
4.
9%
17
3.7%
10
3.
5%
n/a
n/a
50
4.1%
Bla
ck**
99
20
.9%
11
2 24
.1%
65
22
.6%
n/
a n/
a27
6 22
.5%
Am
.In/A
N**
2 0.
4%
2 0.
4%
1 0.
3%
n/a
n/a
5 0.
4%
Asi
an,P
I**
n/a
0.0%
n/
a 0.
0%
n/a
0.0%
n/
a n/
an/
a 0.
0%
His
pani
c 13
2.
7%
5 1.
1%
4 1.
4%
n/a
n/a
22
1.8%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Fem
ale
Tota
l 13
7 29
.0%
13
6 29
.3%
80
27
.8%
n/
a n/
a35
3 28
.8%
Whi
te**
12
4 26
.2%
12
3 26
.5%
74
25
.7%
n/
a n/
a32
1 26
.2%
Bla
ck**
28
9 61
.1%
30
1 64
.9%
18
9 65
.6%
n/
a n/
a77
9 63
.6%
Am
.In/A
N**
3 0.
6%
4 0.
9%
3 1.
0%
n/a
n/a
10
0.8%
Asi
an,P
I**
2 0.
4%
1 0.
2%
1 0.
3%
n/a
n/a
4 0.
3%
His
pani
c 55
11
.6%
35
7.
5%
20
6.9%
n/
a n/
a11
0 9.
0%
Unk
now
n n/
a 0.
0%
n/a
0.0%
1
0.3%
n/
a n/
a1
0.1%
Tota
l
Tota
l 47
3 10
0.0%
464
100.
0%28
8 10
0.0%
n/
a n/
a1,
225
100.
0%
**n
on H
ispa
nic;
Am
. In/
AN
= A
mer
ican
Indi
an/A
lask
an N
ativ
e; A
sian
, PI=
Asi
an/P
acifi
c Is
land
er
† H
IV D
isea
se in
clud
es a
ll ne
wly
repo
rted
HIV
infe
cted
indi
vidu
als
by th
e da
te o
f firs
t rep
ort (
HIV
or A
IDS
)
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
HIV
/STD
Pre
v. &
Car
e
9
Nor
th C
arol
ina
HIV
† Dis
ease
Cas
es b
y G
ende
r and
Mod
e of
Tra
nsm
issi
on, 2
007
1st Q
tr
2nd
Qtr
3r
d Q
tr
4th
Qtr
Ye
ar to
Dat
e M
OD
E O
F TR
AN
SMIS
SIO
N
Cas
esPc
t C
ases
Pct
Cas
es
Pct
Cas
esPc
tC
ases
Pct
MSM
**
176
37.2
%
163
35.1
%
105
36.5
%
n/a
n/a
444
36.2
%
IDU
**
14
3.0%
9
1.9%
6
2.1%
n/
a n/
a29
2.
4%
MSM
/IDU
9
1.9%
7
1.5%
2
0.7%
n/
a n/
a18
1.
5%
Blo
od P
rodu
cts*
* n/
a 0.
0%
5 1.
1%
n/a
0.0%
n/
a n/
a5
0.4%
Het
eros
exua
l con
tact
11
2.
3%
17
3.7%
9
3.1%
n/
a n/
a37
3.
0%
Pres
umed
het
eros
exua
l35
7.
4%
36
7.8%
17
5.
9%
n/a
n/a
88
7.2%
Pedi
atric
2
0.4%
1
0.2%
1
0.3%
n/
a n/
a4
0.3%
Ris
k no
t spe
cifie
d 89
18
.8%
90
19
.4%
68
23
.6%
n/
a n/
a24
7 20
.2%
Mal
e
Tota
l 33
6 71
.0%
32
8 70
.7%
20
8 72
.2%
n/
a n/
a87
2 71
.2%
IDU
**
13
2.7%
5
1.1%
3
1.0%
n/
a n/
a21
1.
7%
Blo
od P
rodu
cts*
* 3
0.6%
2
0.4%
1
0.3%
n/
a n/
a6
0.5%
Het
eros
exua
l con
tact
28
5.
9%
26
5.6%
15
5.
2%
n/a
n/a
69
5.6%
Pres
umed
het
eros
exua
l44
9.
3%
28
6.0%
24
8.
3%
n/a
n/a
96
7.8%
Pedi
atric
n/
a 0.
0%
2 0.
4%
n/a
0.0%
n/
a n/
a2
0.2%
Ris
k no
t spe
cifie
d 49
10
.4%
73
15
.7%
37
12
.8%
n/
a n/
a15
9 13
.0%
Fem
ale
Tota
l 13
7 29
.0%
13
6 29
.3%
80
27
.8%
n/
a n/
a35
3 28
.8%
MSM
**
176
37.2
%
163
35.1
%
105
36.5
%
n/a
n/a
444
36.2
%
IDU
**
27
5.7%
14
3.
0%
9 3.
1%
n/a
n/a
50
4.1%
MSM
/IDU
9
1.9%
7
1.5%
2
0.7%
n/
a n/
a18
1.
5%
Blo
od P
rodu
cts*
* 3
0.6%
7
1.5%
1
0.3%
n/
a n/
a11
0.
9%
Het
eros
exua
l con
tact
39
8.
2%
43
9.3%
24
8.
3%
n/a
n/a
106
8.7%
Pres
umed
het
eros
exua
l79
16
.7%
64
13
.8%
41
14
.2%
n/
a n/
a18
4 15
.0%
Pedi
atric
2
0.4%
3
0.6%
1
0.3%
n/
a n/
a6
0.5%
Ris
k no
t spe
cifie
d 13
8 29
.2%
16
3 35
.1%
10
5 36
.5%
n/
a n/
a40
6 33
.1%
Tota
l
Tota
l 47
3 10
0.0%
464
100.
0%28
8 10
0.0%
n/a
n/a
1,22
510
0.0%
*
*MS
M=
men
who
hav
e se
x w
ith m
en; I
DU
= in
trave
nous
dru
g us
e; “B
lood
pro
duct
s” in
clud
es a
dult
hem
ophi
lia; “
Pre
sum
ed h
eter
osex
ual”
incl
udes
re
ports
initi
ally
cla
ssifi
ed a
s “r
isk
not
spec
ified
” w
ith a
dditi
onal
risk
info
rmat
ion
cons
iste
nt w
ith h
eter
osex
ual t
rans
mis
sion
;
†H
IV D
isea
se in
clud
es a
ll ne
wly
repo
rted
HIV
infe
cted
indi
vidu
als
by th
e da
te o
f firs
t rep
ort (
HIV
or A
IDS
)
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
HIV
/STD
Pre
v. &
Car
e
10 N
orth
Car
olin
a C
hlam
ydia
Cas
es b
y G
ende
r and
Age
, 200
7
1st Q
tr
2nd
Qtr
3r
d Q
tr
4th
Qtr
Ye
ar to
Dat
e A
GE
Cas
esPc
t C
ases
Pct
Cas
esPc
t C
ases
Pct
Cas
esPc
t
0-12
Yea
rs
4 0.
1%
2 0.
0%
n/a
0.0%
n/
a n/
a6
0.0%
13-1
9 Ye
ars
323
4.2%
35
1 5.
0%
307
3.9%
n/
a n/
a98
1 4.
3%
20-2
9 Ye
ars
861
11.2
%
832
11.9
%
792
10.0
%
n/a
n/a
2,48
5 11
.0%
30-3
9 Ye
ars
179
2.3%
18
5 2.
7%
180
2.3%
n/
a n/
a54
4 2.
4%
40-4
9 Ye
ars
62
0.8%
56
0.
8%
73
0.9%
n/
a n/
a19
1 0.
8%
50 a
nd o
ver
18
0.2%
17
0.
2%
31
0.4%
n/
a n/
a66
0.
3%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Mal
e
Tota
l 1,
447
18.9
%
1,44
320
.7%
1,
383
17.4
%
n/a
n/a
4,27
3 18
.9%
0-12
Yea
rs
3 0.
0%
11
0.2%
8
0.1%
n/
a n/
a22
0.
1%
13-1
9 Ye
ars
2,46
132
.1%
2,
194
31.5
%
2,64
533
.3%
n/
a n/
a7,
300
32.3
%
20-2
9 Ye
ars
3,18
641
.6%
2,
830
40.6
%
3,29
241
.4%
n/
a n/
a9,
308
41.2
%
30-3
9 Ye
ars
465
6.1%
39
0 5.
6%
511
6.4%
n/
a n/
a1,
366
6.1%
40-4
9 Ye
ars
78
1.0%
83
1.
2%
86
1.1%
n/
a n/
a24
7 1.
1%
50 a
nd o
ver
16
0.2%
17
0.
2%
27
0.3%
n/
a n/
a60
0.
3%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Fem
ale
Tota
l 6,
209
81.1
%
5,52
579
.3%
6,
569
82.6
%
n/a
n/a
18,3
0381
.1%
0-12
Yea
rs
7 0.
1%
13
0.2%
8
0.1%
n/
a n/
a28
0.
1%
13-1
9 Ye
ars
2,78
436
.4%
2,
545
36.5
%
2,95
237
.1%
n/
a n/
a8,
281
36.7
%
20-2
9 Ye
ars
4,04
752
.9%
3,
662
52.6
%
4,08
451
.4%
n/
a n/
a11
,793
52.2
%
30-3
9 Ye
ars
644
8.4%
57
5 8.
3%
691
8.7%
n/
a n/
a1,
910
8.5%
40-4
9 Ye
ars
140
1.8%
13
9 2.
0%
159
2.0%
n/
a n/
a43
8 1.
9%
50 a
nd o
ver
34
0.4%
34
0.
5%
58
0.7%
n/
a n/
a12
6 0.
6%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Tota
l
Tota
l 7,
656
100.
0%6,
968
100.
0%7,
952
100.
0%n/
a n/
a22
,576
100.
0%
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
HIV
/STD
Pre
v. &
Car
e
11 N
orth
Car
olin
a C
hlam
ydia
Cas
es b
y G
ende
r and
Rac
e/Et
hnic
ity, 2
007
1s
t Qtr
2n
d Q
tr
3rd
Qtr
4t
h Q
tr
Year
to D
ate
RA
CE/
ETH
NIC
ITY
Cas
esPc
t C
ases
Pct
Cas
esPc
t C
ases
Pct
Cas
esPc
t
Whi
te**
27
9 3.
6%
254
3.6%
27
2 3.
4%
n/a
n/a
805
3.6%
Bla
ck**
96
8 12
.6%
90
4 13
.0%
84
4 10
.6%
n/
a n/
a2,
716
12.0
%
Am
.In/A
N**
10
0.1%
10
0.
1%
5 0.
1%
n/a
n/a
25
0.1%
Asi
an,P
I**
10
0.1%
17
0.
2%
11
0.1%
n/
a n/
a38
0.
2%
His
pani
c 11
9 1.
6%
123
1.8%
14
3 1.
8%
n/a
n/a
385
1.7%
Unk
now
n 61
0.
8%
135
1.9%
10
8 1.
4%
n/a
n/a
304
1.3%
Mal
e
Tota
l 1,
447
18.9
%
1,44
320
.7%
1,
383
17.4
%
n/a
n/a
4,27
3 18
.9%
Whi
te**
1,
610
21.0
%
1,27
218
.3%
1,
633
20.5
%
n/a
n/a
4,51
5 20
.0%
Bla
ck**
3,
512
45.9
%
3,00
543
.1%
3,
722
46.8
%
n/a
n/a
10,2
3945
.4%
Am
.In/A
N**
83
1.1%
78
1.
1%
79
1.0%
n/
a n/
a24
0 1.
1%
Asi
an,P
I**
42
0.5%
43
0.
6%
41
0.5%
n/
a n/
a12
6 0.
6%
His
pani
c 43
3 5.
7%
422
6.1%
49
7 6.
3%
n/a
n/a
1,35
2 6.
0%
Unk
now
n 52
9 6.
9%
705
10.1
%
597
7.5%
n/
a n/
a1,
831
8.1%
Fem
ale
Tota
l 6,
209
81.1
%
5,52
579
.3%
6,
569
82.6
%
n/a
n/a
18,3
0381
.1%
Whi
te**
1,
889
24.7
%
1,52
621
.9%
1,
905
24.0
%
n/a
n/a
5,32
0 23
.6%
Bla
ck**
4,
480
58.5
%
3,90
956
.1%
4,
566
57.4
%
n/a
n/a
12,9
5557
.4%
Am
.In/A
N**
93
1.2%
88
1.
3%
84
1.1%
n/
a n/
a26
5 1.
2%
Asi
an,P
I**
52
0.7%
60
0.
9%
52
0.7%
n/
a n/
a16
4 0.
7%
His
pani
c 55
2 7.
2%
545
7.8%
64
0 8.
0%
n/a
n/a
1,73
7 7.
7%
Unk
now
n 59
0 7.
7%
840
12.1
%
705
8.9%
n/
a n/
a2,
135
9.5%
Tota
l
Tota
l 7,
656
100.
0%6,
968
100.
0%7,
952
100.
0%n/
a n/
a22
,576
100.
0%
**
non
His
pani
c; A
m. I
n/AN
= A
mer
ican
Indi
an/A
lask
an N
ativ
e; A
sian
, PI=
Asi
an/P
acifi
c Is
land
er
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
HIV
/STD
Pre
v. &
Car
e
12 N
orth
Car
olin
a G
onor
rhea
Cas
es b
y G
ende
r and
Age
, 200
7
1st Q
tr
2nd
Qtr
3r
d Q
tr
4th
Qtr
Ye
ar to
Dat
e A
GE
Cas
esPc
t C
ases
Pct
Cas
esPc
t C
ases
Pct
Cas
esPc
t
0-12
Yea
rs
n/a
0.0%
n/
a 0.
0%
2 0.
1%
n/a
n/a
2 0.
0%
13-1
9 Ye
ars
266
7.0%
32
7 10
.1%
32
0 10
.5%
n/
a n/
a91
3 9.
1%
20-2
9 Ye
ars
879
23.1
%
919
28.4
%
976
32.1
%
n/a
n/a
2,77
4 27
.5%
30-3
9 Ye
ars
370
9.7%
35
1 10
.9%
36
0 11
.8%
n/
a n/
a1,
081
10.7
%
40-4
9 Ye
ars
191
5.0%
19
0 5.
9%
199
6.6%
n/
a n/
a58
0 5.
8%
50 a
nd o
ver
102
2.7%
10
7 3.
3%
95
3.1%
n/
a n/
a30
4 3.
0%
Unk
now
n 1
0.0%
n/
a 0.
0%
n/a
0.0%
n/
a n/
a1
0.0%
Mal
e
Tota
l 1,
809
47.5
%
1,89
458
.6%
1,
952
64.3
%
n/a
n/a
5,65
5 56
.1%
0-12
Yea
rs
1 0.
0%
6 0.
2%
1 0.
0%
n/a
n/a
8 0.
1%
13-1
9 Ye
ars
689
18.1
%
465
14.4
%
344
11.3
%
n/a
n/a
1,49
8 14
.9%
20-2
9 Ye
ars
1,02
626
.9%
66
3 20
.5%
58
0 19
.1%
n/
a n/
a2,
269
22.5
%
30-3
9 Ye
ars
205
5.4%
14
8 4.
6%
116
3.8%
n/
a n/
a46
9 4.
7%
40-4
9 Ye
ars
71
1.9%
44
1.
4%
37
1.2%
n/
a n/
a15
2 1.
5%
50 a
nd o
ver
9 0.
2%
10
0.3%
5
0.2%
n/
a n/
a24
0.
2%
Unk
now
n n/
a 0.
0%
2 0.
1%
3 0.
1%
n/a
n/a
5 0.
0%
Fem
ale
Tota
l 2,
001
52.5
%
1,33
841
.4%
1,
086
35.7
%
n/a
n/a
4,42
5 43
.9%
0-12
Yea
rs
1 0.
0%
6 0.
2%
3 0.
1%
n/a
n/a
10
0.1%
13-1
9 Ye
ars
955
25.1
%
792
24.5
%
664
21.9
%
n/a
n/a
2,41
1 23
.9%
20-2
9 Ye
ars
1,90
550
.0%
1,
582
48.9
%
1,55
651
.2%
n/
a n/
a5,
043
50.0
%
30-3
9 Ye
ars
575
15.1
%
499
15.4
%
476
15.7
%
n/a
n/a
1,55
0 15
.4%
40-4
9 Ye
ars
262
6.9%
23
4 7.
2%
236
7.8%
n/
a n/
a73
2 7.
3%
50 a
nd o
ver
111
2.9%
11
7 3.
6%
100
3.3%
n/
a n/
a32
8 3.
3%
Unk
now
n 1
0.0%
2
0.1%
3
0.1%
n/
a n/
a6
0.1%
Tota
l
Tota
l 3,
810
100.
0%3,
232
100.
0%3,
038
100.
0%
n/a
n/a
10,0
8010
0.0%
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
HIV
/STD
Pre
v. &
Car
e
13
N
orth
Car
olin
a G
onor
rhea
Cas
es b
y G
ende
r and
Rac
e/Et
hnic
ity, 2
007
1s
t Qtr
2n
d Q
tr
3rd
Qtr
4t
h Q
tr
Year
to D
ate
RA
CE/
ETH
NIC
ITY
Cas
esPc
t C
ases
Pct
Cas
esPc
t C
ases
Pct
Cas
esPc
t
Whi
te**
20
3 5.
3%
189
5.8%
22
3 7.
3%
n/a
n/a
615
6.1%
Bla
ck**
1,
402
36.8
%
1,46
745
.4%
1,
487
48.9
%
n/a
n/a
4,35
6 43
.2%
Am
.In/A
N**
9 0.
2%
18
0.6%
12
0.
4%
n/a
n/a
39
0.4%
Asi
an,P
I**
8 0.
2%
8 0.
2%
6 0.
2%
n/a
n/a
22
0.2%
His
pani
c 53
1.
4%
48
1.5%
79
2.
6%
n/a
n/a
180
1.8%
Unk
now
n 13
4 3.
5%
164
5.1%
14
5 4.
8%
n/a
n/a
443
4.4%
Mal
e
Tota
l 1,
809
47.5
%
1,89
458
.6%
1,
952
64.3
%
n/a
n/a
5,65
5 56
.1%
Whi
te**
41
5 10
.9%
25
1 7.
8%
217
7.1%
n/
a n/
a88
3 8.
8%
Bla
ck**
1,
358
35.6
%
890
27.5
%
685
22.5
%
n/a
n/a
2,93
3 29
.1%
Am
.In/A
N**
19
0.5%
31
1.
0%
14
0.5%
n/
a n/
a64
0.
6%
Asi
an,P
I**
8 0.
2%
4 0.
1%
4 0.
1%
n/a
n/a
16
0.2%
His
pani
c 40
1.
0%
27
0.8%
20
0.
7%
n/a
n/a
87
0.9%
Unk
now
n 16
1 4.
2%
135
4.2%
14
6 4.
8%
n/a
n/a
442
4.4%
Fem
ale
Tota
l 2,
001
52.5
%
1,33
841
.4%
1,
086
35.7
%
n/a
n/a
4,42
5 43
.9%
Whi
te**
61
8 16
.2%
44
0 13
.6%
44
0 14
.5%
n/
a n/
a1,
498
14.9
%
Bla
ck**
2,
760
72.4
%
2,35
772
.9%
2,
172
71.5
%
n/a
n/a
7,28
9 72
.3%
Am
.In/A
N**
28
0.7%
49
1.
5%
26
0.9%
n/
a n/
a10
3 1.
0%
Asi
an,P
I**
16
0.4%
12
0.
4%
10
0.3%
n/
a n/
a38
0.
4%
His
pani
c 93
2.
4%
75
2.3%
99
3.
3%
n/a
n/a
267
2.6%
Unk
now
n 29
5 7.
7%
299
9.3%
29
1 9.
6%
n/a
n/a
885
8.8%
Tota
l
Tota
l 3,
810
100.
0%3,
232
100.
0%3,
038
100.
0%n/
a n/
a10
,080
100.
0%
**n
on H
ispa
nic;
Am
. In/
AN
= A
mer
ican
Indi
an/A
lask
an N
ativ
e; A
sian
, PI=
Asi
an/P
acifi
c Is
land
er
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
HIV
/STD
Pre
v. &
Car
e
14 N
orth
Car
olin
a Ea
rly S
yphi
lis C
ases
by
Gen
der a
nd A
ge, 2
007
1s
t Qtr
2n
d Q
tr
3rd
Qtr
4t
h Q
tr
Year
to D
ate
AG
E C
ases
Pct
Cas
esPc
t C
ases
Pct
Cas
esPc
tC
ases
Pct
0-12
Yea
rs
n/a
0.0%
n/
a 0.
0%
n/a
0.0%
n/
a n/
an/
a 0.
0%
13-1
9 Ye
ars
6 3.
8%
6 4.
3%
6 5.
2%
n/a
n/a
18
4.4%
20-2
9 Ye
ars
36
22.6
%
25
18.0
%
29
25.2
%
n/a
n/a
90
21.8
%
30-3
9 Ye
ars
28
17.6
%
33
23.7
%
20
17.4
%
n/a
n/a
81
19.6
%
40-4
9 Ye
ars
33
20.8
%
25
18.0
%
14
12.2
%
n/a
n/a
72
17.4
%
50 a
nd o
ver
15
9.4%
12
8.
6%
8 7.
0%
n/a
n/a
35
8.5%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Mal
e
Tota
l 11
8 74
.2%
10
1 72
.7%
77
67
.0%
n/
a n/
a29
6 71
.7%
0-12
Yea
rs
n/a
0.0%
n/
a 0.
0%
n/a
0.0%
n/
a n/
an/
a 0.
0%
13-1
9 Ye
ars
1 0.
6%
3 2.
2%
2 1.
7%
n/a
n/a
6 1.
5%
20-2
9 Ye
ars
14
8.8%
12
8.
6%
15
13.0
%
n/a
n/a
41
9.9%
30-3
9 Ye
ars
10
6.3%
13
9.
4%
11
9.6%
n/
a n/
a34
8.
2%
40-4
9 Ye
ars
14
8.8%
7
5.0%
10
8.
7%
n/a
n/a
31
7.5%
50 a
nd o
ver
2 1.
3%
3 2.
2%
n/a
0.0%
n/
a n/
a5
1.2%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Fem
ale
Tota
l 41
25
.8%
38
27
.3%
38
33
.0%
n/
a n/
a11
7 28
.3%
0-12
Yea
rs
n/a
0.0%
n/
a 0.
0%
n/a
0.0%
n/
a n/
an/
a 0.
0%
13-1
9 Ye
ars
7 4.
4%
9 6.
5%
8 7.
0%
n/a
n/a
24
5.8%
20-2
9 Ye
ars
50
31.4
%
37
26.6
%
44
38.3
%
n/a
n/a
131
31.7
%
30-3
9 Ye
ars
38
23.9
%
46
33.1
%
31
27.0
%
n/a
n/a
115
27.8
%
40-4
9 Ye
ars
47
29.6
%
32
23.0
%
24
20.9
%
n/a
n/a
103
24.9
%
50 a
nd o
ver
17
10.7
%
15
10.8
%
8 7.
0%
n/a
n/a
40
9.7%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Tota
l
Tota
l 15
9 10
0.0%
139
100.
0%11
5 10
0.0%
n/
a n/
a41
3 10
0.0%
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
HIV
/STD
Pre
v. &
Car
e
15 N
orth
Car
olin
a Ea
rly S
yphi
lis C
ases
by
Gen
der a
nd R
ace/
Ethn
icity
, 200
7
1st Q
tr
2nd
Qtr
3r
d Q
tr
4th
Qtr
Ye
ar to
Dat
e R
AC
E/ET
HN
ICIT
Y C
ases
Pct
Cas
esPc
t C
ases
Pct
Cas
esPc
tC
ases
Pct
Whi
te**
33
20
.8%
20
14
.4%
16
13
.9%
n/
a n/
a69
16
.7%
Bla
ck**
77
48
.4%
79
56
.8%
52
45
.2%
n/
a n/
a20
8 50
.4%
Am
.In/A
N**
2 1.
3%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
2 0.
5%
Asi
an,P
I**
1 0.
6%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
1 0.
2%
His
pani
c 5
3.1%
1
0.7%
8
7.0%
n/
a n/
a14
3.
4%
Unk
now
n n/
a 0.
0%
1 0.
7%
1 0.
9%
n/a
n/a
2 0.
5%
Mal
e
Tota
l 11
8 74
.2%
10
1 72
.7%
77
67
.0%
n/
a n/
a29
6 71
.7%
Whi
te**
4
2.5%
10
7.
2%
10
8.7%
n/
a n/
a24
5.
8%
Bla
ck**
36
22
.6%
24
17
.3%
23
20
.0%
n/
a n/
a83
20
.1%
Am
.In/A
N**
n/a
0.0%
1
0.7%
1
0.9%
n/
a n/
a2
0.5%
Asi
an,P
I**
n/a
0.0%
1
0.7%
n/
a 0.
0%
n/a
n/a
1 0.
2%
His
pani
c 1
0.6%
2
1.4%
4
3.5%
n/
a n/
a7
1.7%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Fem
ale
Tota
l 41
25
.8%
38
27
.3%
38
33
.0%
n/
a n/
a11
7 28
.3%
Whi
te**
37
23
.3%
30
21
.6%
26
22
.6%
n/
a n/
a93
22
.5%
Bla
ck**
11
3 71
.1%
10
3 74
.1%
75
65
.2%
n/
a n/
a29
1 70
.5%
Am
.In/A
N**
2 1.
3%
1 0.
7%
1 0.
9%
n/a
n/a
4 1.
0%
Asi
an,P
I**
1 0.
6%
1 0.
7%
n/a
0.0%
n/
a n/
a2
0.5%
His
pani
c 6
3.8%
3
2.2%
12
10
.4%
n/
a n/
a21
5.
1%
Unk
now
n n/
a 0.
0%
1 0.
7%
1 0.
9%
n/a
n/a
2 0.
5%
Tota
l
Tota
l 15
9 10
0.0%
139
100.
0%11
5 10
0.0%
n/a
n/a
413
100.
0%
**
non
His
pani
c; A
m. I
n/AN
= A
mer
ican
Indi
an/A
lask
an N
ativ
e; A
sian
, PI=
Asi
an/P
acifi
c Is
land
er
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
HIV
/STD
Pre
v. &
Car
e
16 N
orth
Car
olin
a A
IDS
Cas
es b
y G
ende
r and
Age
, 200
7
1st Q
tr
2nd
Qtr
3r
d Q
tr
4th
Qtr
Ye
ar to
Dat
e A
GE
Cas
esPc
t C
ases
Pct
Cas
esPc
t C
ases
Pct
Cas
esPc
t
0-12
Yea
rs
n/a
0.0%
n/
a 0.
0%
n/a
0.0%
n/
a n/
an/
a 0.
0%
13-1
9 Ye
ars
1 0.
4%
1 0.
4%
3 1.
4%
n/a
n/a
5 0.
7%
20-2
9 Ye
ars
26
10.3
%
26
11.1
%
18
8.5%
n/
a n/
a70
10
.0%
30-3
9 Ye
ars
41
16.2
%
44
18.8
%
37
17.5
%
n/a
n/a
122
17.5
%
40-4
9 Ye
ars
68
26.9
%
69
29.5
%
55
26.1
%
n/a
n/a
192
27.5
%
50 a
nd o
ver
37
14.6
%
32
13.7
%
34
16.1
%
n/a
n/a
103
14.8
%
Mal
e
Tota
l 17
3 68
.4%
17
2 73
.5%
14
7 69
.7%
n/
a n/
a49
2 70
.5%
0-12
Yea
rs
n/a
0.0%
1
0.4%
n/
a 0.
0%
n/a
n/a
1 0.
1%
13-1
9 Ye
ars
n/a
0.0%
n/
a 0.
0%
2 0.
9%
n/a
n/a
2 0.
3%
20-2
9 Ye
ars
6 2.
4%
5 2.
1%
11
5.2%
n/
a n/
a22
3.
2%
30-3
9 Ye
ars
25
9.9%
14
6.
0%
22
10.4
%
n/a
n/a
61
8.7%
40-4
9 Ye
ars
33
13.0
%
27
11.5
%
19
9.0%
n/
a n/
a79
11
.3%
50 a
nd o
ver
16
6.3%
15
6.
4%
10
4.7%
n/
a n/
a41
5.
9%
Fem
ale
Tota
l 80
31
.6%
62
26
.5%
64
30
.3%
n/
a n/
a20
6 29
.5%
0-12
Yea
rs
n/a
0.0%
1
0.4%
n/
a 0.
0%
n/a
n/a
1 0.
1%
13-1
9 Ye
ars
1 0.
4%
1 0.
4%
5 2.
4%
n/a
n/a
7 1.
0%
20-2
9 Ye
ars
32
12.6
%
31
13.2
%
29
13.7
%
n/a
n/a
92
13.2
%
30-3
9 Ye
ars
66
26.1
%
58
24.8
%
59
28.0
%
n/a
n/a
183
26.2
%
40-4
9 Ye
ars
101
39.9
%
96
41.0
%
74
35.1
%
n/a
n/a
271
38.8
%
50 a
nd o
ver
53
20.9
%
47
20.1
%
44
20.9
%
n/a
n/a
144
20.6
%
Tota
l
Tota
l 25
3 10
0.0%
234
100.
0%21
1 10
0.0%
n/
a n/
a69
8 10
0.0%
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
HIV
/STD
Pre
v. &
Car
e
17 N
orth
Car
olin
a A
IDS
Cas
es b
y G
ende
r and
Rac
e/Et
hnic
ity, 2
007
1s
t Qtr
2n
d Q
tr
3rd
Qtr
4t
h Q
tr
Year
to D
ate
RA
CE/
ETH
NIC
ITY
Cas
esPc
t C
ases
Pct
Cas
esPc
t C
ases
Pct
Cas
esPc
t
Whi
te**
36
14
.2%
39
16
.7%
37
17
.5%
n/
a n/
a11
2 16
.0%
Bla
ck**
11
5 45
.5%
11
5 49
.1%
94
44
.5%
n/
a n/
a32
4 46
.4%
Am
.In/A
N**
3 1.
2%
1 0.
4%
n/a
0.0%
n/
a n/
a4
0.6%
Asi
an,P
I**
1 0.
4%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
1 0.
1%
His
pani
c 18
7.
1%
17
7.3%
15
7.
1%
n/a
n/a
50
7.2%
Unk
now
n n/
a 0.
0%
n/a
0.0%
1
0.5%
n/
a n/
a1
0.1%
Mal
e
Tota
l 17
3 68
.4%
17
2 73
.5%
14
7 69
.7%
n/
a n/
a49
2 70
.5%
Whi
te**
16
6.
3%
6 2.
6%
7 3.
3%
n/a
n/a
29
4.2%
Bla
ck**
57
22
.5%
52
22
.2%
55
26
.1%
n/
a n/
a16
4 23
.5%
Am
.In/A
N**
2 0.
8%
2 0.
9%
2 0.
9%
n/a
n/a
6 0.
9%
Asi
an,P
I**
n/a
0.0%
1
0.4%
n/
a 0.
0%
n/a
n/a
1 0.
1%
His
pani
c 5
2.0%
1
0.4%
n/
a 0.
0%
n/a
n/a
6 0.
9%
Unk
now
n n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Fem
ale
Tota
l 80
31
.6%
62
26
.5%
64
30
.3%
n/
a n/
a20
6 29
.5%
Whi
te**
52
20
.6%
45
19
.2%
44
20
.9%
n/
a n/
a14
1 20
.2%
Bla
ck**
17
2 68
.0%
16
7 71
.4%
14
9 70
.6%
n/
a n/
a48
8 69
.9%
Am
.In/A
N**
5 2.
0%
3 1.
3%
2 0.
9%
n/a
n/a
10
1.4%
Asi
an,P
I**
1 0.
4%
1 0.
4%
n/a
0.0%
n/
a n/
a2
0.3%
His
pani
c 23
9.
1%
18
7.7%
15
7.
1%
n/a
n/a
56
8.0%
Unk
now
n n/
a 0.
0%
n/a
0.0%
1
0.5%
n/
a n/
a1
0.1%
Tota
l
Tota
l 25
3 10
0.0%
234
100.
0%21
1 10
0.0%
n/
a n/
a69
8 10
0.0%
*
*non
His
pani
c; A
m. I
n/A
N=
Am
eric
an In
dian
/Ala
skan
Nat
ive;
Asi
an, P
I= A
sian
/Pac
ific
Isla
nder
NC
HIV
/STD
Qua
rterly
Sur
veill
ance
Rep
ort V
ol. 2
007
No.
3
NC
DH
HS
HIV
/STD
Pre
v. &
Car
e
18
Nor
th C
arol
ina
AID
S C
ases
by
Gen
der a
nd M
ode
of T
rans
mis
sion
, 200
7
1st Q
tr
2nd
Qtr
3r
d Q
tr
4th
Qtr
Ye
ar to
Dat
e M
OD
E O
F TR
AN
SMIS
SIO
N
Cas
esPc
t C
ases
Pct
Cas
es
Pct
Cas
esPc
tC
ases
Pct
MSM
**
65
25.7
%
61
26.1
%
57
27.0
%
n/a
n/a
183
26.2
%
IDU
**
12
4.7%
7
3.0%
11
5.
2%
n/a
n/a
30
4.3%
MSM
/IDU
6
2.4%
7
3.0%
4
1.9%
n/
a n/
a17
2.
4%
Blo
od P
rodu
cts*
* 1
0.4%
1
0.4%
n/
a 0.
0%
n/a
n/a
2 0.
3%
Het
eros
exua
l con
tact
9
3.6%
13
5.
6%
11
5.2%
n/
a n/
a33
4.
7%
Pres
umed
het
eros
exua
l32
12
.6%
27
11
.5%
18
8.
5%
n/a
n/a
77
11.0
%
Pedi
atric
n/
a 0.
0%
n/a
0.0%
n/
a 0.
0%
n/a
n/a
n/a
0.0%
Ris
k no
t spe
cifie
d 48
19
.0%
56
23
.9%
46
21
.8%
n/
a n/
a15
0 21
.5%
Mal
e
Tota
l 17
3 68
.4%
17
2 73
.5%
14
7 69
.7%
n/
a n/
a49
2 70
.5%
IDU
**
6 2.
4%
7 3.
0%
5 2.
4%
n/a
n/a
18
2.6%
Blo
od P
rodu
cts*
* 2
0.8%
2
0.9%
2
0.9%
n/
a n/
a6
0.9%
Het
eros
exua
l con
tact
28
11
.1%
16
6.
8%
19
9.0%
n/
a n/
a63
9.
0%
Pres
umed
het
eros
exua
l15
5.
9%
13
5.6%
17
8.
1%
n/a
n/a
45
6.4%
Pedi
atric
n/
a 0.
0%
1 0.
4%
1 0.
5%
n/a
n/a
2 0.
3%
Ris
k no
t spe
cifie
d 29
11
.5%
23
9.
8%
20
9.5%
n/
a n/
a72
10
.3%
Fem
ale
Tota
l 80
31
.6%
62
26
.5%
64
30
.3%
n/
a n/
a20
6 29
.5%
MSM
**
65
25.7
%
61
26.1
%
57
27.0
%
n/a
n/a
183
26.2
%
IDU
**
18
7.1%
14
6.
0%
16
7.6%
n/
a n/
a48
6.
9%
MSM
/IDU
6
2.4%
7
3.0%
4
1.9%
n/
a n/
a17
2.
4%
Blo
od P
rodu
cts*
* 3
1.2%
3
1.3%
2
0.9%
n/
a n/
a8
1.1%
Het
eros
exua
l con
tact
37
14
.6%
29
12
.4%
30
14
.2%
n/
a n/
a96
13
.8%
Pres
umed
het
eros
exua
l47
18
.6%
40
17
.1%
35
16
.6%
n/
a n/
a12
2 17
.5%
Pedi
atric
n/
a 0.
0%
1 0.
4%
1 0.
5%
n/a
n/a
2 0.
3%
Ris
k no
t spe
cifie
d 77
30
.4%
79
33
.8%
66
31
.3%
n/
a n/
a22
2 31
.8%
Tota
l
Tota
l 25
3 10
0.0%
234
100.
0%21
1 10
0.0%
n/a
n/a
698
100.
0%
**M
SM
= m
en w
ho h
ave
sex
with
men
; ID
U=
intra
veno
us d
rug
use;
“Blo
od p
rodu
cts”
incl
udes
adu
lt he
mop
hilia
; “P
resu
med
het
eros
exua
l” in
clud
es
repo
rts in
itial
ly c
lass
ified
as
“ris
k no
t sp
ecifi
ed ”
with
add
ition
al ri
sk in
form
atio
n co
nsis
tent
with
het
eros
exua
l tra
nsm
issi
on